Literature DB >> 12045120

Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood.

Finn Rasmussen1, D Robin Taylor, Erin M Flannery, Jan O Cowan, Justina M Greene, G Peter Herbison, Malcolm R Sears.   

Abstract

Airway remodeling may lead to irreversible loss of lung function in asthma. The impact of childhood asthma, airway responsiveness, atopy, and smoking on airway remodeling was investigated in a birth cohort studied longitudinally to age 26. A low postbronchodilator ratio of forced exhaled volume in 1 second (FEV1) to vital capacity (VC) at age 18 or 26 was used as a marker of airway remodeling. "Normal" study members with no history of asthma ever, no wheezing in the last year, and no smoking ever were used to determine sex- and age-specific reference values for this ratio. The lower limit of normal was defined as the mean ratio minus 1.96 standard deviation, delimiting the 2.5% of the normal population with the lowest FEV1/VC ratio. A low postbronchodilator FEV1/VC ratio was found in 7.4% and 6.4% of study members at ages 18 and age 26 and 4.6% at both assessments. Lung function was low throughout childhood in those with a consistently low postbronchodilator FEV1/VC ratio at both ages. Those with consistently low postbronchodilator ratios also showed a greater decline in the prebronchodilator FEV1/VC ratio from ages 9 to 26 compared with those with normal postbronchodilator ratios at both ages (males, -12% versus -6%, p < 0.0001; females, -10.5% versus -5.5%, p < 0.01). Asthma, male sex, airway hyperresponsiveness, and low lung function in childhood were each independently associated with a low postbronchodilator FEV1/VC ratio, which in turn was associated with an accelerated decline in lung function and decreased reversibility. These data suggest that airway remodeling in asthma, as manifested by impaired lung function, begins in childhood and continues into adult life.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12045120     DOI: 10.1164/rccm.2108009

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  50 in total

Review 1.  Childhood asthma.

Authors:  Lesley Lowe; Adnan Custovic; Ashley Woodcock
Journal:  Curr Allergy Asthma Rep       Date:  2004-03       Impact factor: 4.806

2.  Airway inflammation in children with difficult asthma: relationships with airflow limitation and persistent symptoms.

Authors:  D N R Payne; Y Qiu; J Zhu; L Peachey; M Scallan; A Bush; P K Jeffery
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

Review 3.  Drug development for severe asthma: what are the metrics?

Authors:  Cynthia B Robinson; Joanne Leonard; Reynold A Panettieri
Journal:  Pharmacol Ther       Date:  2012-05-22       Impact factor: 12.310

4.  Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program.

Authors:  Anne M Fitzpatrick; W Gerald Teague; Deborah A Meyers; Stephen P Peters; Xingnan Li; Huashi Li; Sally E Wenzel; Shean Aujla; Mario Castro; Leonard B Bacharier; Benjamin M Gaston; Eugene R Bleecker; Wendy C Moore
Journal:  J Allergy Clin Immunol       Date:  2010-12-31       Impact factor: 10.793

5.  Inhaled corticosteroids moderate lung function decline in adults with asthma.

Authors:  P Ernst
Journal:  Thorax       Date:  2006-02       Impact factor: 9.139

Review 6.  Epidemiology of stress and asthma: from constricting communities and fragile families to epigenetics.

Authors:  Rosalind J Wright
Journal:  Immunol Allergy Clin North Am       Date:  2011-02       Impact factor: 3.479

7.  Irreversible airway obstruction in asthma.

Authors:  Louis-Philippe Boulet
Journal:  Curr Allergy Asthma Rep       Date:  2009-03       Impact factor: 4.806

8.  Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study.

Authors:  Debra A Stern; Wayne J Morgan; Marilyn Halonen; Anne L Wright; Fernando D Martinez
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

9.  Sputum hyaluronan and versican in severe eosinophilic asthma.

Authors:  Andrew G Ayars; Leonard C Altman; Sue Potter-Perigo; Katherine Radford; Thomas N Wight; Parameswaran Nair
Journal:  Int Arch Allergy Immunol       Date:  2012-12-14       Impact factor: 2.749

Review 10.  Perinatal stress and early life programming of lung structure and function.

Authors:  Rosalind J Wright
Journal:  Biol Psychol       Date:  2010-01-18       Impact factor: 3.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.